Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
518.6 INR | +2.35% | +3.15% | +56.96% |
Apr. 18 | Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US | MT |
Apr. 17 | Shilpa Medicare Gets GMP Certification from Austrian Agency for Telangana, India Unit | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+56.96% | 527M | |
+31.37% | 588B | |
-2.77% | 364B | |
+20.39% | 326B | |
+5.40% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.91% | 167B | |
0.00% | 161B |
- Stock Market
- Equities
- SHILPAMED Stock
- News Shilpa Medicare Limited
- Shilpa Medicare Gets Regulatory Nod for Pemetrexed Injections